Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - Re: "We expect PDS will fund its operations through licensing revenue."

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Back To Forum List View

"We expect PDS will fund its operations through licensing revenue."

gcduck

Oct 17, 2011 04:56PM

Re: "We expect PDS will fund its operations through licensing revenue."

shboomer

Oct 17, 2011 05:01PM

MagnusBuchs

Rank: Treasurer [?]

Points: 582 [?]

Votes: 27 Score: 2.0 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: "We expect PDS will fund its operations through licensing revenue."

in response to

Re: "We expect PDS will fund its operations through licensing revenue."

shboomer

posted on Oct 17, 2011 05:11PM

Watch !

Lekrone will proceed with litigations against infringers of the Core Flash patents with a couple thousand dollars. When funds start running low, he'll license one or two MMP customers...and charge PDS "out the ying-yang" in legal expenses. I hope PTSC is setting up a "Lekrone-Trap" with this strategy.

6 Recommendations

Re: "We expect PDS will fund its operations through licensing revenue."

mikesmark

Oct 17, 2011 05:39PM

Re: "We expect PDS will fund its operations through licensing revenue."

jldmt

Oct 17, 2011 05:53PM

Re: "We expect PDS will fund its operations through licensing revenue."

shboomer

Oct 17, 2011 06:12PM